Drug Shortage Report for NAROPIN

Last updated on 2023-11-28 History
Report ID 203931
Drug Identification Number 02229418
Brand name NAROPIN
Common or Proper name ropivacaine HCl 10mg/mL 5x20mL SU Polyamp® Duofit®
Company Name ASPEN PHARMACARE CANADA INC.
Market Status MARKETED
Active Ingredient(s) ROPIVACAINE HYDROCHLORIDE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration EPIDURAL EPIDURAL
Packaging size 5 PP Polybag
ATC code N01BB
ATC description ANESTHETICS, LOCAL
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2023-11-15
Actual start date 2023-10-17
Estimated end date 2023-12-15
Actual end date 2023-11-22
Shortage status Resolved
Updated date 2023-11-28
Company comments VR89864CA1 NAROPIN 10MG/ML LIQ PP AMP 5X20ML CA ASP
Health Canada comments
Tier 3 Status No
Contact Address UNIT 8, 1155 NORTH SERVICE ROAD WEST
OAKVILLE, ONTARIO
CANADA L6M 3E3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2023-11-28 French Compare
v11 2023-11-28 English Compare
v10 2023-10-18 English Compare
v9 2023-10-17 French Compare
v8 2023-10-17 English Compare
v7 2023-10-10 French Compare
v6 2023-10-10 English Compare
v5 2023-09-23 English Compare
v4 2023-09-15 French Compare
v3 2023-09-15 English Compare
v2 2023-09-08 French Compare
v1 2023-09-08 English Compare

Showing 1 to 12 of 12